|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.34 USD | +3.88% |
|
-2.19% | +31.93% |
Syra Health Corp. provided earnings guidance for 2024. The company anticipates full-year 2024 revenue of $9 to $11 million, representing growth of 64%-100% versus 2023.
Due to the implementation cycle of customers, the Company expects the majority of its contract revenues to be realized in the second half of 2024.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.93% | 17.96M | |
| -35.02% | 12.81B | |
| +4.81% | 11.84B | |
| -3.60% | 11.5B | |
| +10.95% | 10.72B | |
| +27.77% | 8.66B | |
| -10.66% | 7.24B | |
| +12.82% | 7.14B | |
| +9.12% | 6.5B | |
| +10.13% | 4.25B |
SYRA HEALTH CORP. 
